Geode Capital Management LLC Has $911,000 Stake in Alpha Teknova, Inc. (NASDAQ:TKNO)

Geode Capital Management LLC increased its position in Alpha Teknova, Inc. (NASDAQ:TKNO) by 24.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 188,173 shares of the company’s stock after purchasing an additional 36,914 shares during the period. Geode Capital Management LLC’s holdings in Alpha Teknova were worth $911,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of TKNO. Roubaix Capital LLC bought a new position in shares of Alpha Teknova in the 3rd quarter worth $2,015,000. Point72 Asset Management L.P. bought a new position in Alpha Teknova during the 3rd quarter valued at $1,483,000. Finally, State Street Corp lifted its stake in Alpha Teknova by 249.3% during the 3rd quarter. State Street Corp now owns 76,645 shares of the company’s stock valued at $371,000 after acquiring an additional 54,700 shares in the last quarter. 13.81% of the stock is currently owned by institutional investors.

Alpha Teknova Price Performance

Shares of NASDAQ:TKNO opened at $8.06 on Friday. The company has a current ratio of 4.73, a quick ratio of 3.94 and a debt-to-equity ratio of 0.12. The stock’s fifty day simple moving average is $7.71 and its two-hundred day simple moving average is $5.40. Alpha Teknova, Inc. has a 1-year low of $1.15 and a 1-year high of $9.72. The stock has a market cap of $429.66 million, a PE ratio of -10.89 and a beta of 0.34.

Alpha Teknova (NASDAQ:TKNO) last released its earnings results on Thursday, November 7th. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.04). The business had revenue of $9.58 million for the quarter, compared to the consensus estimate of $9.30 million. Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. During the same quarter in the previous year, the firm earned ($0.34) earnings per share. As a group, analysts forecast that Alpha Teknova, Inc. will post -0.58 EPS for the current fiscal year.

Alpha Teknova Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.